Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital

Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Cyclosporine and COVID-19: Risk or favorable?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Renal 123I-MIBG Uptake before and after Live-Donor Kidney Transplantation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Vascular function in adults with cyanotic congenital heart disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Kontinuerlig glukosemonitorering af patienter med type 1- og type 2-diabetes i dialysebehandling

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Felodipine and renal function in lung transplantation: A randomized placebo-controlled trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Esben Iversen
  • Morten Baltzer Houlind
  • Thomas Kallemose
  • Line Jee Hartmann Rasmussen
  • Mads Hornum
  • Bo Feldt-Rasmussen
  • Salim S Hayek
  • Ove Andersen
  • Jesper Eugen-Olsen
Vis graf over relationer

Introduction: Identifying patients at high risk of developing kidney disease could lead to early clinical interventions that prevent or slow disease progression. Soluble urokinase plasminogen activator receptor (suPAR) is an inflammatory biomarker thought to be involved in the pathogenesis and development of kidney disease. We aimed to determine whether elevated plasma suPAR measured at hospital admission is associated with incident kidney disease in patients presenting to the emergency department. Materials and Methods: This was a retrospective registry-based cohort study performed at the Emergency Department of Copenhagen University Hospital Amager and Hvidovre, Hvidovre, Denmark. Patients were included in the study from November 2013 to March 2017 and followed until June 2017. Patients were excluded if they were diagnosed with kidney disease or died prior to index discharge. Plasma suPAR was measured at hospital admission, and the main outcome was time to incident kidney disease, defined by ICD-10 diagnosis codes for both chronic and acute kidney conditions. Association between suPAR and time to incident kidney disease was assessed by Cox proportional hazard regression analysis. Results: In total, 25,497 patients (median age 58.1 years; 52.5% female) were admitted to the emergency department and followed for development of kidney disease. In multivariable Cox regression analysis adjusting for age, sex, eGFR, CRP, cardiovascular disease, hypertension, and diabetes, each doubling in suPAR at hospital admission was associated with a hazard ratio of 1.57 (95% CI: 1.38–1.78, P < 0.001) for developing a chronic kidney condition and 2.51 (95% CI: 2.09–3.01, P < 0.001) for developing an acute kidney condition. Discussion: In a large cohort of acutely hospitalized medical patients, elevated suPAR was independently associated with incident chronic and acute kidney conditions. This highlights the potential for using suPAR in risk classification models to identify high-risk patients who could benefit from early clinical interventions. The main limitation of this study is its reliance on accurate reporting of ICD-10 codes for kidney disease.

TidsskriftFrontiers in Cell and Developmental Biology
Sider (fra-til)1-11
Antal sider11
StatusUdgivet - 12 jun. 2020

Bibliografisk note

Copyright © 2020 Iversen, Houlind, Kallemose, Rasmussen, Hornum, Feldt-Rasmussen, Hayek, Andersen and Eugen-Olsen.

ID: 60230422